Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16505505 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: insulin glargine;   Drug: rosiglitazone;   Drug: metformin

Indicates status has not been verified in more than two years